December 12, 2017
Dr. Neda Laiteerapong’s latest research has been published in the Annals of Internal Medicine. Dr. Laiteerapong’s objective was to estimate the cost-effectiveness of individualized control versus uniform intensive control for the U.S. population with type 2 diabetes. Read the full details here.